Association between Antacid Exposure and Risk of Interstitial Lung Diseases [PDF]
Tuberculosis and Respiratory Diseases, 2023 Background The mechanisms leading to lung fibrosis are still under investigation. This study aimed to demonstrate whether antacids could prevent the development of interstitial lung disease (ILD).
Soohyun Bae +5 more
doaj +4 more sources
Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. [PDF]
PLoS ONE, 2016 Antacid treatments decrease the serum concentrations of first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), although it is unknown whether antacids affect clinical outcomes. As cerebrospinal fluid concentrations of
Yu-Mu Chen +14 more
doaj +2 more sources
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
BMC Pulmonary Medicine, 2019 Background and objective Gastroesophageal reflux disease (GORD) is highly prevalent in idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis.
Helen E. Jo +16 more
doaj +2 more sources
New Natural Marine Antacid Drug from Cuttlebone [PDF]
Pharmaceutical Sciences, 2018 Background: Antacids are the most commonly used medications for fast symptomatic relief of gastric disorders. Because of adverse effects, low efficiency and the high cost of some chemical antacids, identifying a natural medicine with high efficiency and ...
Azar Mostoufi +3 more
doaj +2 more sources
Comparison of Acid-neutralizing capacity of antacids in Erbil City
Zanco Journal of Medical Sciences, 2021 Background and objective: Antacids are basic substances that can neutralize hydrochloric acid and reduce gastric acidity. They are over the counter drugs used to treat dyspepsia. The most commonly used antacids are sodium bicarbonate, magnesium hydroxide,
Dina Aziz Boya, Jwan Mohammed Ahmed
doaj +3 more sources
Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review [PDF]
BMJ Paediatrics Open, 2018 Background Gastro-oesophageal reflux is prevalent in preterm infants. Despite widespread use in clinical practice, there is still much controversy over the efficacy and safety of drug interventions, particularly antacid therapy.Objective To ...
Jon Dorling +4 more
doaj +2 more sources
In Vitro Evaluation of Drug–Drug Interaction Between Gliclazide and Antacids at the Absorption Level [PDF]
PharmaceuticalsBackground: The antidiabetic drug gliclazide is often taken with antacids due to its gastrointestinal side effects. However, patients rarely report antacid use, making drug–drug interactions a potential cause of therapy failure.
Slavica Lazarević +6 more
doaj +2 more sources
Exploratory analyses of meal‐induced heartburn identify distinct clinical phenotypes of gastroesophageal reflux disease [PDF]
Physiological ReportsSymptoms in symptomatic GERD patients result from esophageal acid exposure and are treated with agents that inhibit gastric acid secretion. We analyzed data from a clinical trial evaluating the effect of ranitidine plus antacid on heartburn severity in ...
Jerry D. Gardner +1 more
doaj +2 more sources
Optimal antacid drug selection in clinical practice
Медицинский совет, 2013 Rational pharmacotherapy of acid-base disorders (ABD) of the upper gastrointestinal tract remains relevant due to high prevalence of the pathology, particularly among the working age population, complex etiology and pathogenesis, and availability of a ...
M. I. Schyokina, I. M. Scherbenkov
doaj +2 more sources
Effect of antacid gastric syrups on surface properties of dental restorative materials: an in vitro analysis of roughness and microhardness [PDF]
BMC Oral HealthSummary Objectives The aim of this in-vitro study was to evaluate the effects of antacid gastric syrups on the surface roughness and microhardness of restorative dental materials.
Fikri Öcal, Burak Dayi
doaj +2 more sources